Clinical trial
The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind…
NCT00115895 · University of Helsinki, Other · Unknown status
Key facts
| NCT number | NCT00115895 |
|---|---|
| Title | The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy |
| Official title | Effect of the Radioiodine Dose in Thyroid Ablation- A Randomized Comparison of 1110 MBq to 3700 MBq |
| Lead sponsor | University of Helsinki, Other |
| Collaborators | Helsinki University Central Hospital |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Thyroid Neoplasms |
| Intervention type | Drug |
| Interventions | Radioactive iodine |
| Enrollment | 160 |
| Start date | Jan 1, 2000 |
| Primary completion | Oct 1, 2004 |
| Completion | Sep 1, 2020 |
| First posted | Jun 27, 2005 |
| Last update posted | Mar 2, 2018 |
| Countries | Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: